April 30, 2018 / 5:08 AM / 21 days ago

BRIEF-Kuros Biosciences FY Loss At EUR 16.5 Mln

April 30 (Reuters) - KUROS BIOSCIENCES AG:

* IN 2018, AIMS TO CAPITALIZE ON RESTRUCTURING AS IT EXECUTES ON ITS RENEWED FOCUS ON ORTHOBIOLOGICS

* FY LOSS 16.484 MILLION EUR VERSUS LOSS 19.744 MILLION EUR YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below